JP Morgan Chase’s Dynavax Technologies DVAX Stock Holding History

JP Morgan Chase’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-17,100	Closed	-$152K	–	5533
2020 Q2	$152K	Buy	+17,100	New	+$86.4K	﹤0.01%	4396
2019 Q2	–	Sell	-114,500	Closed	-$837K	–	5803
2019 Q1	$837K	Buy	114,500 +64,500	+129%	+$631K	﹤0.01%	3911
2018 Q4	$458K	Buy	+50,000	New	+$553K	﹤0.01%	4176
2018 Q2	–	Sell	-88,400	Closed	-$1.75M	–	5565
2018 Q1	$1.75M	Buy	+88,400	New	+$1.53M	﹤0.01%	3344

Other funds holding DVAX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

JP Morgan Chase's DVAX Position: Q1 2026 in Review

JP Morgan Chase sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 674,643 shares — an estimated $10.4M sold.

JP Morgan Chase first reported a position in DVAX in Q2 2013 and held it in 44 quarters. The position peaked at $12.1M in Q1 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

JP Morgan Chase reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
JP Morgan Chase sold 674,643 Dynavax Technologies shares in Q1 2026, an estimated $10.4M.
JP Morgan Chase first reported a position in Dynavax Technologies in Q2 2013 and held it in 44 quarters.
JP Morgan Chase's Dynavax Technologies position peaked at $12.1M in Q1 2025.
1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.